🇺🇸 FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12036198

Dosage forms and therapeutic uses of L-4-chlorokynurenine

VISTAGEN THERAPUETICS, INC. · Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10980758

Dosage forms and therapeutic uses of L-4-chlorokynurenine

VISTAGEN THERAPUETICS, INC. · Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10632091

Dosage forms and therapeutic uses of L-4-chlorokynurenine

VISTAGEN THERAPUETICS, INC. · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10617663

Dosage forms and therapeutic uses of L-4-chlorokynurenine

VISTAGEN THERAPUETICS, INC. · Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993453

Dosage forms and therapeutic uses L-4-chlorokynurenine

VISTAGEN THERAPUETICS, INC. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993450

Dosage forms and therapeutic uses of L-4-chlorokynurenine

VISTAGEN THERAPUETICS, INC. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted